GHK Cu Mr & Mrs Peptides GHK Cu FDA Approval Status 2026: Not Approved GHK Cu (Copper Peptide) Therapy in South Florida Prescription Consultation & Medical Evaluation Telehealth Florida Surgery & Weight Loss Center January 2026 FDA New Drug Approvals Zycubo (copper histidinate) Some approvals mark progress. Others redefine what hope looks like. In January 2026, the U.S. FDA approved Zycubo (copper histidinate injection formerly GHK CU (100MG) Ridgeline Resources